Literature DB >> 9798726

Recent advances in assisted reproductive technologies.

F Khamsi1, I Lacanna, M Endman, J Wong.   

Abstract

Assisted reproductive technologies (ART) have received considerable attention, both clinically and empirically. Drs. Steptoe and Edwards removed one oocyte surgically from a woman with infertility related to tubal disease. They fertilized this oocyte in vitro and transferred the formed embryo to the woman's uterus and achieved pregnancy and delivery. The technique of in vitro fertilization (IVF) and embryo transfer (ET) quickly became widely utilized for other causes of infertility as well as for tubal disease. In the last 5 years there has been a number of new developments that are reviewed in this article. The most important and now widely practiced technology has been direct intracytoplasmic injection (ICSI) of the husband's sperm into the wife's oocyte. This was developed for treatment of infertility related to low sperm count. Subsequently it was shown that sperm can be aspirated from epididymis or found in testicular biopsy in obstructive azoospermia. Another promising development is in vitro maturation (IVM) of immature oocytes. This has the potential of avoiding ovarian hyperstimulation, which can be uncomfortable and occasionally dangerous. Some oocytes are unable to fertilize and/or develop into normal embryos. It may be possible that the problem is with the machinery of cytoplasm of the oocyte. Therefore cytoplasmic transfer from a normal oocyte to an abnormal oocyte may overcome the problem. Infertile couples may be faced with many psychological problems that become even more complex with various treatments. Whereas donation of oocytes or embryos can be technically quite simple, there are many psychological issues involved. As can be gathered from aforementioned discussions, the treatments developed for infertility appear to be somewhat illogical and in the style of "shot gun therapy." In the field of infertility, as in other areas of medicine, it is of paramount importance to know the details of disease mechanisms. This in turn will allow specific and logical treatments to be developed.

Entities:  

Mesh:

Year:  1998        PMID: 9798726     DOI: 10.1385/ENDO:9:1:15

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.925


  67 in total

1.  Impairment of the hatching process following IVF in the human and improvement of implantation by assisting hatching using micromanipulation.

Authors:  J Cohen; C Elsner; H Kort; H Malter; J Massey; M P Mayer; K Wiemer
Journal:  Hum Reprod       Date:  1990-01       Impact factor: 6.918

2.  A survey of parental attitudes toward oocyte donation.

Authors:  D Pettee; L N Weckstein
Journal:  Hum Reprod       Date:  1993-11       Impact factor: 6.918

3.  Oocyte donors: a demographic analysis of women at the University of Southern California.

Authors:  M V Sauer; R J Paulson
Journal:  Hum Reprod       Date:  1992-05       Impact factor: 6.918

4.  Prospective follow-up study of 423 children born after intracytoplasmic sperm injection.

Authors:  M Bonduelle; J Legein; A Buysse; E Van Assche; A Wisanto; P Devroey; A C Van Steirteghem; I Liebaers
Journal:  Hum Reprod       Date:  1996-07       Impact factor: 6.918

5.  Relation between antisperm antibodies and the rate of fertilization of human oocytes in vitro.

Authors:  S S Witkin; D Viti; S S David; J Stangel; Z Rosenwaks
Journal:  J Assist Reprod Genet       Date:  1992-02       Impact factor: 3.412

6.  Some psychological aspects of oocyte donation from known donors on altruistic basis.

Authors:  F Khamsi; M W Endman; I C Lacanna; J Wong
Journal:  Fertil Steril       Date:  1997-08       Impact factor: 7.329

7.  Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group.

Authors:  A S Whittemore; R Harris; J Itnyre
Journal:  Am J Epidemiol       Date:  1992-11-15       Impact factor: 4.897

8.  The incidence of chromosomal aneuploidy in stimulated and unstimulated (natural) uninseminated human oocytes.

Authors:  L Gras; J McBain; A Trounson; I Kola
Journal:  Hum Reprod       Date:  1992-11       Impact factor: 6.918

9.  Physiological consequences of loss of plasminogen activator gene function in mice.

Authors:  P Carmeliet; L Schoonjans; L Kieckens; B Ream; J Degen; R Bronson; R De Vos; J J van den Oord; D Collen; R C Mulligan
Journal:  Nature       Date:  1994-03-31       Impact factor: 49.962

10.  Assisted hatching in the treatment of poor prognosis in vitro fertilization candidates.

Authors:  W B Schoolcraft; T Schlenker; M Gee; G S Jones; H W Jones
Journal:  Fertil Steril       Date:  1994-09       Impact factor: 7.329

View more
  5 in total

1.  Performing ICSI using an injection pipette with the smallest possible inner diameter and a long taper increases normal fertilization rate, decreases incidence of degeneration and tripronuclear zygotes, and enhances embryo development.

Authors:  Y Yavas; S Roberge; F Khamsi; P Shirazi; M W Endman; J C Wong
Journal:  J Assist Reprod Genet       Date:  2001-08       Impact factor: 3.412

2.  Effects of granulosa cells, cumulus cells, and oocyte density on in vitro fertilization in women.

Authors:  F Khamsi; S Roberge; I C Lacanna; J Wong; Y Yavas
Journal:  Endocrine       Date:  1999-04       Impact factor: 3.633

3.  Novel studies on influence of gonadotropins and insulin-like growth factor-I on growth of cumulus oophorus in the rat.

Authors:  F Khamsi; S Roberge
Journal:  Endocrine       Date:  2000-02       Impact factor: 3.633

4.  Epidemiologic Approaches for Studying Assisted Reproductive Technologies: Design, Methods, Analysis and Interpretation.

Authors:  Carmen Messerlian; Audrey J Gaskins
Journal:  Curr Epidemiol Rep       Date:  2017-04-17

5.  Exposure of human oocytes to endometrioma fluid does not alter fertilization or early embryo development.

Authors:  F Khamsi; Y Yavas; I C Lacanna; S Roberge; M Endman; J C Wong
Journal:  J Assist Reprod Genet       Date:  2001-02       Impact factor: 3.412

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.